Home>News Center>China
       
 

SARS vaccine found safe in test
By Fu Jing (China Daily)
Updated: 2004-12-05 22:01

The first-phase human test of a vaccine for severe acute respiratory syndrome (SARS), developed by Chinese scientists, proved that it is safe and effective.

As the first of the worldwide vaccine teams to finish first-phase clinical trials, the national research team said that China has taken the lead in the global race to develop a remedy for the deadly illness, according to sources from the Ministry of Science and Technology.

Team head Yin Weidong said all 36 volunteers receiving the SARS vaccine in the clinical tests showed no obvious side effects and antibodies had been produced in their bodies.

"We have finished our first-phase clinical test in line with international vaccine-testing requirements," said Yin, adding that the phase is mainly aimed at evaluating the safety of the vaccine.

Thirty-six healthy volunteers aged between 21 and 40 took part in the trials which began on May 22 and ended at the end of last month.

Eighteen received an injection of a low-dosage SARS inactivated vaccine while the remaining 18 received a high dosage.

Yin said antibodies in volunteers' blood serum were produced and except for such minor side effects as fever and discomfort, volunteers showed no other adverse reactions and their health was in good condition.

More than 100 leading researchers and scientists nationwide have taken part in the programme jointly launched by the Ministry of Science and Technology, the Ministry of Health and the State Food and Drug Administration.

At least 10 different types of SARS vaccines are under development, as cited by an earlier report from the science ministry.

Four of them, developed by Canada and the United States, will go into clinical trials by the end of this year. Vaccines developed by France and Austria will likely be at the same stage next year.

The first SARS case was recorded in the southern province of Guangdong in November 2002.

The epidemic killed over 770 people worldwide, most of them in Asia, before subsiding in June.



 
  Today's Top News     Top China News
 

SARS vaccine found safe in test

 

   
 

Speculative money: A hot potato for China

 

   
 

Rumsfeld to stay as US defense secretary

 

   
 

25 dead, 19 missing at Guizhou landslides

 

   
 

Job company predicts white collar income

 

   
 

Generation raised with internet grows up

 

   
  Ministry's control on railways questioned
   
  25 dead, 19 missing at Guizhou landslides
   
  Dishonesty centre of 'Junen crisis?'
   
  Job company predicts white collar income
   
  Traffic accident kills 15 in Guangxi
   
  Legislation targets risky behaviour by children
   
 
  Go to Another Section  
 
 
  Story Tools  
   
  Related Stories  
   
Expert: SARS vaccine good so far
   
China batch-produces SARS reagent
   
No SARS vaccine available soon
   
Beijing installs SARS early-warning system
   
China bans slaughter, cooking of civets
   
Expert warns SARS odd cases
  News Talk  
  It is time to prepare for Beijing - 2008  
Advertisement